Chemoinformaics analysis of (2E)-N-(2-Methylbutyl)-2-undecene-8,10-diynamide
| Molecular Weight | 245.366 | nRot | 8 |
| Heavy Atom Molecular Weight | 222.182 | nRig | 4 |
| Exact Molecular Weight | 245.178 | nRing | 0 |
| Solubility: LogS | -3.2 | nHRing | 0 |
| Solubility: LogP | 3.655 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 43.9582 |
| nHD | 1 | BPOL | 24.5118 |
| QED | 0.397 |
| Synth | 3.585 |
| Natural Product Likeliness | 1.46 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.036 |
| CACO-2 | -3.771 |
| MDCK | 0.0000966 |
| BBB | 0.333 |
| PPB | 0.972434 |
| VDSS | 0.833 |
| FU | 0.0128575 |
| CYP1A2-inh | 0.935 |
| CYP1A2-sub | 0.471 |
| CYP2c19-inh | 0.947 |
| CYP2c19-sub | 0.529 |
| CYP2c9-inh | 0.843 |
| CYP2c9-sub | 0.939 |
| CYP2d6-inh | 0.655 |
| CYP2d6-sub | 0.729 |
| CYP3a4-inh | 0.8 |
| CYP3a4-sub | 0.159 |
| CL | 11.533 |
| T12 | 0.536 |
| hERG | 0.011 |
| Ames | 0.521 |
| ROA | 0.059 |
| SkinSen | 0.952 |
| Carcinogencity | 0.915 |
| EI | 0.853 |
| Respiratory | 0.926 |
| NR-Aromatase | 0.016 |
| Antiviral | Yes |
| Prediction | 0.770574 |